|

Imaging Agent Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Image Enhancement Agent

Pipeline

Phase 2/3: 1

Top Sponsors

  • NRG Oncology1

Indications

  • Upper Alveolar Ridge Squamous Cell Carcinoma1
  • Retromolar Trigone Squamous Cell Carcinoma1
  • Lower Alveolar Ridge Squamous Cell Carcinoma1
  • Lip Squamous Cell Carcinoma1
  • Hard Palate Squamous Cell Carcinoma1

Birmingham, Alabama1 trial

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

University of Alabama at Birmingham Cancer Center

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.